CDKN2B and cancer: c-Myc directly associates with the MH2 domain of SMAD2 and SMAD3 to inhibit the TGF-β-induced transcriptional activity of Sp1 and SMAD/Sp1-dependent transcriptions of the p15Ink4B gene and eventually promotes cell growth and cancer progression [21].